medline.ch Gastroenterologie Oesophagus Neoplasie

	Misreporting of study design and validation status in a study of early tumour shrinkage in esophageal squamous cell carcinoma. Cancer Imaging Khodamoradi E. PMID: 42907938 [PubMed - indexed for MEDLINE]
	Acetic acid chromoendoscopy for detection of neoplastic Barrett's oesophagus: stepped wedge cluster randomised controlled trial (ACID-trial). BMJ Beaufort IN, Boer LS, Milne AN, Alderlieste YA, Baars JE, Bos PR, Burger JPW, van Heel NCM, Ledeboer M, Lieverse RJ, van de Meeberg PC, Meeuse JJ, Naber AHJ, Pullens HJM, Scheffer RCH, Sikkema M, Stolk MFJ, Verbeek RE, Verhagen MAMT, van de Vrie W, Willems M, van Werkhoven CH, Weusten BLAM. PMID: 42907095 [PubMed - indexed for MEDLINE]
	A dual-prompt framework combining spatial-mask priors and clinical-text conditioning for CT-only GTV delineation in esophageal cancer: A multicenter study. Med Phys Sun H, Chen C, Chen J, Wang Q, Li J, An Z, Liu Y, Meng F, Jia L, Shi Z, Cui Y, Liu Y, Gong J, Huang D, Zhao L. PMID: 42905882 [PubMed - indexed for MEDLINE]
	Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer. Front Immunol Pang Y, Jiang P, Liu K, Suo X, Zhang D, Xu Y, Ge Y, Fu Q, Gao S. PMID: 42903418 [PubMed - indexed for MEDLINE]
	Can Current Innovations in Diagnostic and Therapeutic Strategies Transform Gastroesophageal Cancer Care? Middle East J Dig Dis Alshwayyat S, Almasri N, Maraqa K, Abu Samrah S, Aljawabrah S, Abuhalaweh N, Alshwaiyat Y, Al-Shami R, Al-Zoubi L, Alswaiti Y, Altaweel H, Abid R, Alqasem K, Al-Kurdi MA. PMID: 42903379 [PubMed]
	Immune-related adverse events are associated with favorable clinical outcomes in esophageal cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Front Oncol Fan J, Chen D, Jia L. PMID: 42903106 [PubMed]
	Study protocol of a prospective, non-interventional cohort study evaluating the benefits of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma receiving first-line atezolizumab plus bevacizumab (NISTIPS TRITICC-4, IKF092). Future Oncol Angendohr C, Weigel C, Kunstein A, Joerdens M, Goetze T, Al-Batran SE, Zäpf B, Gonzalez-Carmona M, Sahin C, Berres ML, Foerster F, Ben Khaled N, Koch C, Kandulski A, Wege H, Trebicka J, Jochheim LS, Dill MT, Springfeld C, Daum S, Treese C, Ehmer U, Luedde T, Bode J, Roderburg C. PMID: 42902603 [PubMed - as supplied by publisher]
	Eosinophilic Oesophagitis and Incidence of Gastrointestinal Cancer: A Population-Based Cohort Study. Aliment Pharmacol Ther Kurt G, Farkas DK, Dellon ES, Jensen ET, Sørensen HT. PMID: 42902446 [PubMed - as supplied by publisher]
	Effectiveness of personalized positioning management in preventing hypoxemia during sedated endoscopy: a retrospective study. BMC Gastroenterol Chen Y, Zhu J. PMID: 42902208 [PubMed - indexed for MEDLINE]
	Combined TIPS and TACE for patients with hepatocellular carcinoma and variceal bleeding secondary to portal vein tumor thrombus. BMC Gastroenterol Feng Z, Wu B, Xu Z, Yang W, Zhou H, Shi H, Liu S, Zhou W. PMID: 42902152 [PubMed - indexed for MEDLINE]
	Ociperlimab and tislelizumab in advanced esophageal squamous cell carcinoma (AdvanTIG-203): a phase II study. Nat Commun Wang F, Lin CY, Sun JM, Lu CH, Zhu X, Chen Z, Zhao Q, Kim IH, Pan Y, Zhang J, Chen Z, Tougeron D, Kim SB, Van Cutsem E, Zaanan A, Rivera F, Dechaphunkul A, Zuo Y, Wan Q, Zhang J, Zhou J, Xu RH. PMID: 42901884 [PubMed - indexed for MEDLINE]
	Management of cT2N0M0 esophageal cancer: a systematic review and meta-analysis. Dis Esophagus Eliya Y, Leng S, Litle VR, Asghari M, Kohn GP. PMID: 42900766 [PubMed - indexed for MEDLINE]
	Prognostic analysis of remarkable response after radiotherapy or chemoradiotherapy in esophageal cancer. Dis Esophagus Nishiue K, Hayashi Y, Sugioka H, Yoneda S, Adachi Y, Tajiri A, Fukuda H, Kimura E, Uema R, Yoshihara T, Tsujii Y, Makino T, Doki Y, Kodama T. PMID: 42900765 [PubMed - indexed for MEDLINE]
	Gut microbiota in esophageal cancer: mechanisms, clinical implications, and therapeutic potential. Front Microbiol Li Y, Zhou L, Huang R, Wang Y, Zhao H, Sun M, Zhang Y, Wu Z, Li J. PMID: 42898827 [PubMed]
	Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous Cell Carcinoma: From Normal Epithelium to Precancerous Lesions and Carcinoma. Cancer Commun (Lond) Lan L, Wang X, Jiang X, Lin X, Lai Y, Tan W, Zhang S, Lin D, Wu C. PMID: 42898679 [PubMed - indexed for MEDLINE]
	ADH7 and plasma proteins mediate smoking-related esophageal cancer: genetic causality and therapeutic insight. Front Med (Lausanne) Pan L, Yang X, Hao Q, Xie K, Ma H. PMID: 42898182 [PubMed]
	MAIT cells in gastrointestinal cancer: immunity to therapy. Trends Cancer Li YR, Chen Y, Yeh S, Yuen T, Yang L. PMID: 42897051 [PubMed - as supplied by publisher]
	Oesophagectomy following endoscopic resection for oesophageal carcinoma: A Dutch nationwide retrospective cohort study. Eur J Surg Oncol de Kock MA, Khoma O, Pittacolo M, van der Sluis PC, Lagarde SM, Koch AD, Spaander MCW, Nikkessen S, Wijnhoven BPL, Dutch Upper GI Audit group. PMID: 42896400 [PubMed - as supplied by publisher]
	Increased risk of cancer in patients with mixed connective tissue disease: a population-based cohort study in Korea. Clin Rheumatol Choi SJ, Park S, Park M, Choi SW, Lim DH. PMID: 42895612 [PubMed - as supplied by publisher]
	Clinical efficacy and safety of immunotherapy after concurrent chemoradiotherapy in advanced esophageal cancer. J Cardiothorac Surg Hu C, Liu Y, Yang Z, Chen Q, Tong Y, Da B, Sun Y, Rao H. PMID: 42894226 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 39917

Seite 1 von 1996

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung